5 Fights Over $25B Actavis-Forest Deal Merge In NY
A New York judge on Monday consolidated five shareholder class actions pending in the state that are seeking to block generic-drug maker Actavis PLC's proposed $25 billion acquisition of Carl Icahn-backed...To view the full article, register now.
Already a subscriber? Click here to view full article